Clinical Trial Update: Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports results for temozolomide in patients with recurrent glioblastoma multiforme or other malignant gliomas, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED | Results posted: 2016-02-29